Opioid Prescriptions by U.S. Primary Care Physicians From 1992 to 2001

Journal of Pain

Volumn 7, Issue 4, 2006, Pages 225-235

  Olsen, Yngvild ^a   Daumit, Gail L ^a,b,c   Ford, Daniel E ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

health services; Opioid; pain; prescribing patterns; primary care

Indexed keywords

ANALGESIC AGENT; BUPRENORPHINE; BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE SULFATE; NALBUPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAMORPH SR; OXYCODONE; PARACETAMOL; PENTAZOCINE; PETHIDINE; PROSTAGLANDIN SYNTHASE INHIBITOR; TRAMADOL;

ACUTE DISEASE; ARTHRITIS; ARTICLE; BACKACHE; CHRONIC DISEASE; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED DRUG RELEASE; DRUG INDICATION; DRUG UTILIZATION; EPIDEMIOLOGICAL DATA; ETHNOLOGY; GEOGRAPHIC DISTRIBUTION; HEADACHE; HEALTH CARE ORGANIZATION; HISPANIC; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAID; MEDICARE; MUSCULOSKELETAL DISEASE; PAIN; PHYSICIAN; POSTMARKETING SURVEILLANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; TREND STUDY; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; UNITED STATES;

EID: 33646510314     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2005.11.006     Document Type: Article

References (94)

1. National Center for Health Statistics. 1992 National Ambulatory Medical Care Survey Data File Documentation (1994), US Department of Health and Human Services, Hyattsville, MD
2. National Center for Health Statistics. 1993 National Ambulatory Medical Care Survey Data File Documentation (1996), US Department of Health and Human Services, Hyattsville, MD
3. National Center for Health Statistics. 1994 National Ambulatory Medical Care Survey Data File Documentation (1997), US Department of Health and Human Services, Hyattsville, MD
4. National Center for Health Statistics. 1995 National Ambulatory Medical Care Survey Data File Documentation (1997), US Department of Health and Human Services, Hyattsville, MD
5. National Center for Health Statistics. 1996 National Ambulatory Medical Care Survey Data File Documentation (1998), US Department of Health and Human Services, Hyattsville, MD
6. National Center for Health Statistics. 1997 National Ambulatory Medical Care Survey Data File Documentation (1999), US Department of Health and Human Services, Hyattsville, MD
7. National Center for Health Statistics. 1998 National Ambulatory Medical Care Survey Data File Documentation (2000), US Department of Health and Human Services, Hyattsville, MD
8. National Center for Health Statistics. 1999 National Ambulatory Medical Care Survey Data File Documentation (2001), US Department of Health and Human Services, Hyattsville, MD
9. National Center for Health Statistics. 2000 National Ambulatory Medical Care Survey Data File Documentation (2003), US Department of Health and Human Services, Hyattsville, MD
10. National Center for Health Statistics. 2001 National Ambulatory Medical Care Survey Data File Documentation (2004), US Department of Health and Human Services, Hyattsville, MD
11. Adams C. Painkiller's sales far exceeded levels anticipated by maker (2002) Wall Street Journal, May 16
12. Adams N.J., Plane M.B., Fleming M.F., Mundt M.P., Saunders L.A., and Stauffacher E.A. Opioids and the treatment of chronic pain in a primary care sample. J Pain Symptom Manage 22 (2001) 791-796
13. Adams R.J., Armstrong E.P., and Erstad B.L. Prescribing and self-administration of morphine in hispanic and non hispanic caucasian patients treated with patient-controlled analgesia. J Pain Palliat Care Pharmacother 18 (2004) 29-38
14. Albert T: Death fuels brouhaha over OxyContin prescribing practices. Available at: www.ama-assn.org/sci-pubs/amnews/pick_01/prsc0820.htm. Accessed March 16, 2003
15. Albert T, Adams D: OxyContin crackdown raises physician, patient concerns. Available at: www.ama-assn.org/sci-pubs/amnews/pick_01/prl10625.htm. Accessed March 16, 2003
16. American Academy of Pain Medicine, and American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement. Clin J Pain 13 (1997) 6-8
17. American Society of Anesthesiologists Task Force on Pain Management, and Chronic Pain Section. Practice guidelines for chronic pain management. Anesthesiology 86 (1997) 995-1004
18. Arthritis Pain Guideline Panel. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis. 2nd ed. (2002), American Pain Society, Glenview, IL
19. Ballantyne J.C., and Mao J. Opioid therapy for chronic pain. N Engl J Med 349 (2003) 1943-1953
20. Barnett C.L., California Department of Consumer Affairs and Summit Committee, and Summit on Effective Pain Management. Removing impediments to appropriate prescribing (1994), California Department of Consumer Affairs. http://www.druglibrary.org/schaffer/asap/psum.htm Available at: www.druglibrary.org/schaffer/asap/psum.htm. Accessed September 30, 2005
21. Bendtsen P., Hensing G., Ebeling C., and Schedin A. What are the qualities of dilemmas experienced when prescribing opioids in general practice?. Pain 82 (1999) 89-96
22. Benjamin L.J., Dampier C.C., Jacox A.K., Odesina V., Phoenix D., Shapiro B., Strafford M., and Treadwell M. Guideline for the management of acute and chronic pain in sickle-cell disease. APS Clinical Practice Guideline Series No. 1 (1999), American Pain Society, Glenview, IL
23. Berardi D., Leggieri G., Ceroni G.B., Rucci P., Pezzoli A., Paltrinieri E., Grazian N., and Ferrari G. Depression in primary care. A nationwide epidemiological survey. Fam Pract 19 (2000) 397-400
24. Billi J.E., Wise C.G., Sher S.I., Duran-Arenas L., and Shapiro L. Selection in a preferred provider organization enrollment. Health Serv Res 28 (1993) 563-575
25. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H., Abboud P.A., and Rubin H.R. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 282 (1999) 1458-1465
26. Caudill-Slosberg M.A., Schwartz L.M., and Woloshin S. Office Visits and analgesic prescriptions for musculoskeletal pain in US. 1980 vs 2000. Pain 109 (2004) 514-519
27. Centers for Medicare and Medicaid Services. Who Is Eligible for Medicaid? (2004), US Department of Health and Human Services. http://www.cms.hhs.gov/medicaid/whoiseligible.asp November 18, Available at: www.cms.hhs.gov/medicaid/whoiseligible.asp. Accessed March 12, 2004
28. Centers for Medicare and Medicaid Services. Who Is Eligible for Medicaid? (2004), US Department of Health and Human Services. http://www.medicare.gov/MedicareEligibility/Home.asp?dest=NAV%20/Home/%2 0GeneralEnrollment%23TabTop December 9, Available at: www.medicare.gov/MedicareEligibility/Home.asp?dest=NAV/Home/GeneralEnrol lment#TabTop. Accessed September 30, 2005
29. Chibnall J.T., Tait R.C., and Ross L.R. The effects of medical evidence and pain intensity on medical student judgments of chronic pain patients. J Behav Med 20 (1997) 257-271
30. Choi D.M., Yate P., Coats T., Kalinda P., and Paul E.A. Ethnicity and prescription of analgesia in an accident and emergency department. Cross sectional study. BMJ 320 (2000) 980-981
31. Clark H.W., and Sees K.L. Opioids, chronic pain, and the law. J Pain Symptom Manage 8 (1993) 297-305
32. Clark J.D. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 23 (2002) 131-137
33. Cohen S.J., Halvorson H.W., and Gosselink C.A. Changing physician behavior to improve disease prevention. Prev Med 23 (1994) 284-291
34. de Andrade L.T. Management of chronic conditions at Kaiser Permanente. Sonoma Medicine (2003). http://www.scma.org/magazine/scp/wn04/tinti_deAndrade.html Available at: www.scma.org/magazine/scp/wn04/tinti_deAndrade.html. Accessed September 30, 2005
35. Drug Enforcement Administration, Domestic Strategic Intelligence Unit, and Office of Diversion Control. Drug intelligence brief: OxyContin: Pharmaceutical diversion (2002), US Department of Justice Drug Enforcement Administration. http://www.usdoj.gov/dea/pubs/intel/02017/02017.html Available at: www.usdoj.gov/dea/pubs/intel/02017/02017.html. Accessed September 30, 2005
36. Ericsson M., Poston W.S., Linder J., Taylor J.E., Haddock C.K., and Foreyt J.P. Depression predicts disability in long-term chronic pain patients. Disabil Rehabil 24 (2002) 334-340
37. Federation of State Medical Boards of the United States. Model policy for the use of controlled substances for the treatment of pain (2002). http://www.fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf Available at: www.fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf. Accessed September 11, 2005
38. Fishbain D.A., Cutler R., Rosomoff H.L., and Rosomoff R.S. Chronic pain-associated depression. Antecedent or consequence of chronic pain? A review. Clin J Pain 13 (1997) 116-137
39. Fisher M.A. Physicians and the pharmaceutical industry. A dysfunctional relationship. Perspect Biol Med 46 (2003) 254-272
40. Fisher M.A., and Glass S. Butorphanol (Stadol). a study in problems of current drug information and control. Neurology 48 (1997) 1156-1160
41. Frank-Stromborg M., and Christensen A. A serious look at the undertreatment of pain. Part I. Clin J Oncol Nurs 5 (2001) 235-236
42. Frank-Stromborg M., and Christensen A. A serious look at the undertreatment of pain. Part II. Clin J Oncol Nurs 5 (2001) 276-278
43. Gallagher R.M. Primary care and pain medicine. A community solution to the public health problem of chronic pain. Med Clin North Am 83 (1999) 555-583
44. Gallagher R.M., and Verma S. Managing pain and comorbid depression. A public health challenge. Semin Clin Neuropsychiatry 4 (1999) 203-220
45. Geba G.P., Weaver A.L., Polis A.B., Dixon M.E., and Schnitzer T.J. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee. A randomized trial. JAMA 287 (2002) 64-71
46. Glajchen M. Chronic Pain. Treatment barriers and strategies for clinical practice. J Am Board Fam Pract 14 (2001) 211-218
47. Gottlieb L.K., Margolis C.Z., and Schoenbaum S.C. Clinical practice guidelines at an HMO. Development and implementation in a quality improvement model. QRB Qual Rev Bull 16 (1990) 80-86
48. Grimshaw J.M., Eccles M.P., Walker A.E., and Thomas R.E. Changing Physicians' Behavior. What Works and Thoughts on Getting More Things to Work. J Contin Educ Health Prof 22 (2002) 237-243
49. Hagen N., Flynne P., Hays H., and MacDonald N. Guidelines for managing chronic non-malignant pain. opioids and other agents. College of Physicians and Surgeons of Alberta. Can Fam Physician 41 (1995) 49-53
50. Harvard Pilgrim Health Care. Disease and health risk management (2005). http://www.harvardpilgrim.org/portal/page?_pageid=253,41752&_dad= portal&_schema=PORTAL Available at: www.harvardpilgrim.org/portal/page?_pageid=253,41752&_dad= portal& _schema=PORTAL. Accessed September 30, 2005
51. Hill Jr. C.S. Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin. J Pain Symptom Manage 11 (1996) 287-298
52. International Classification of Diseases, 9th Revision, Clinical Modification 2000 (1999), Practice Management Information Corporation, Los Angeles, CA
53. International Marketing Services. Potential of the COX-2 inhibitor market (2000), IMS Health. http://www.ims-global.com/insight/news_story/news_story_000330a.htm March 30, Available at: www.ims-global.com/insight/news_story/news_story_000330a.htm. Accessed October 5, 2004
54. Joranson D.E. State medical board guidelines for treatment of intractable pain. APS Bull 5 (1995) 1-5
55. Joranson D.E., and Gilson A.M. State intractable pain policy. Current status. APS Bull 7 (1997) 7-9
56. Joranson D.E., Carrow G.M., Ryan K.M., Schaefer L., Gilson A.M., Good P., Eadie J., Peine S., and Dahl J.L. Pain management and prescription monitoring. J Pain Symptom Manage 23 (2002) 231-238
57. Juarez G., Ferrell B., and Borneman T. Influence of Culture on cancer pain management in hispanic patients. Cancer Pract 6 (1998) 262-269
58. Kaczor B: US FL: Panhandle doctor's OxyContin conviction to send message. Denver Rocky Mountain News, February 20, 2002
59. Krames E. Techniques of pain management. In: Raj P.P. (Ed). Practical Management of Pain, 3rd ed (2000), Mosby, St Louis, MO 441
60. Luo X., Pietrobon R., and Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine 29 (2004) 884-890
61. Maly R.C. Early recognition of chemical dependence. Prim Care 20 (1993) 33-50
62. Markovich M. The rise of HMOs. Rand Graduate School (2003). http://www.rand.org/publications/RGSD/RGSD172/RGSD172.ch2.pdf Available at: www.rand.org/publications/RGSD/RGSD172/RGSD172.ch2.pdf. Accessed September 30, 2005
63. Marks R.M., and Sachar E.J. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 78 (1973) 173-181
64. Martino A.M. In search of a new ethic for treating patients with chronic pain. What can medical boards do?. J Law Med Ethics 26 (1998) 332-349
65. McCarberg B.H., and Barkin R.L. Long-acting opioids for chronic pain. Pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther 8 (2001) 181-186
66. McElderry R. Pain management. New California standards, requirements, and options. San Francisco Med 75 (2002) 24-25
67. Medical Board of California. New laws related to continuing medical education: AB 487: Pain management and the appropriate care and treatment of the terminally ill (2004). http://www.medbd.ca.gov/CME_Laws.htm Available at: www.medbd.ca.gov/CME_Laws.htm. Accessed September 29, 2005
68. Medical marijuana in California (2003), Institute of Governmental Studies, University of California. http://www.igs.berkeley.edu/library/htMedical/Marijuana2003.html Available at: www.igs.berkeley.edu/library/htMedical/Marijuana2003.html. Accessed May 28, 2003
69. Meier B. OxyContin prescribers face charges in fatal overdoses (2002), New York Times January 19
70. Meier B, Petersen M: Sales of painkiller grew rapidly, but success brought a high cost. New York Times, March 5, 2001
71. Mishra R: Painkiller tears through Maine. Boston Globe, March 23, 2001
72. Morgan J.P. American opiophobia. customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse 5 (1985) 163-173
73. National Center for Health Statistics. NAMCS data file documentation, 1973-1992. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/namcs_public_use_files/. Accessed May 5, 2003
74. National Center for Health Statistics. NAMCS data file documentation, 1993-2002. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Datasets/NAMCS/. Accessed May 5, 2003
75. National Center for Health Statistics. Survey instrument NAMCS (2005), Centers for Disease Control, National Center for Health Statistics. http://www.cdc.gov/nchs/about/major/ahcd/surinst.htm%23Survey%20Instrume nt%20NAMCS Available at: www.cdc.gov/nchs/about/major/ahcd/surinst.htm#Survey%20Instrument%20NAMC S. Accessed August 25, 2005
76. Olfson M., Shea S., Feder A., Fuentes M., Nomura Y., Gameroff M., and Weissman M.M. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med 9 (2000) 876-883
77. Olfson M., Tobin J.N., Cassells A., and Weissman M. Improving the detection of drug abuse, alcohol abuse, and depression in community health centers. J Health Care Poor Underserved 14 (2003) 386-402
78. Olsen Y., and Daumit G.L. Opioid prescribing for chronic nonmalignant pain in primary care. Challenges and solutions. Adv Psychosom Med 25 (2004) 138-150
79. Oregon Department of Human Services: Oregon administrative rules 2002: Compilation medical marijuana. Available at: www.dhs.state.or.us/publichealth/mm/oarrev.cfm. Accessed May 28, 2003
80. Reid M.C., Engles-Horton L.L., Weber M.B., Kerns R.D., Rogers E.L., and O'Connor P.G. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 17 (2002) 173-179
81. Rich B.A. Prioritizing pain management in patient care. Has the time come for a new approach?. Postgrad Med 110 (2001) 15-17
82. Roth S.H., Fleischmann R.M., Burch F.X., Dietz F., Bockow B., Rapoport R.J., Rutstein J., and Lacouture P.G. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain. Placebo-controlled trial and long-term evaluation. Arch Intern Med 160 (2000) 853-860
83. Sanders K.M., and Satyvavolu A. Improving blood pressure control in diabetes. Limitations of a clinical reminder in influencing physician behavior. J Contin Educ Health Prof 22 (2002) 23-32
84. Savage S.R. Long-term opioid therapy. assessment of consequences and risks. J Pain Symptom Manage 11 (1996) 274-286
85. Scientific Advisory Committee. Clinical practice guidelines. Reflex Sympathetic dystrophy/complex regional pain syndrome. In: Kirkpatrick A.F. (Ed). Milford, CT, Reflex Sympathetic Dystrophy Syndrome Association of America (2000). http://www.rsds.org/3/clinical_guidelines/index.html Available at: http://www.rsds.org/3/clinical_guidelines/index.html
86. Sigler K.A., Guernsey B.G., Ingrim N.B., Buesing A.S., Hokanson J.A., Galvan E., and Doutre W.H. Effect of a triplicate prescription law on prescribing of Schedule II drugs. Am J Hosp Pharm 41 (1984) 108-111
87. Steinman M.A., Landefeld C.S., and Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 289 (2003) 719-725
88. American Pain Society. Pain. The fifth vital sign (2003). http://www.ampainsoc.org/advocacy/fifth.htm Available at: www.ampainsoc.org/advocacy/fifth.htm. Accessed April 2, 2003
89. Todd K.H., Samaroo N., and Hoffman J.R. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA 269 (1993) 1537-1539
90. Turk D.C., and Okifuji A. What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients?. Clin J Pain 13 (1997) 330-336
91. Valigra L: Painful realities: The business of pain management has become almost as complex as treating pain itself. Available at: www.ama-assn.org/sci-pubs/amnews/pick_98/feat1214.htm. Accessed August 25, 2005
92. Washington State: Washington state medical use of marijuana act. Initiative Measure No. 692, Chapter 2; Paragraph 1, November 3, 1998
93. Watson C.P., and Babul N. Efficacy of oxycodone in neuropathic pain. A randomized trial in postherpetic neuralgia. Neurology 50 (1998) 1837-1841
94. Wittchen H.U., Kessler R.C., Beesdo K., Krause P., Hofler M., and Hoyer J. Generalized anxiety and depression in primary care. Prevalence, Recognition, and management. J Clin Psychiatry 63 Suppl 8 (2002) 24-34